Value of PET for Stage III Cutaneous Melanoma
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Value of PET for Stage III Cutaneous Melanoma

› Forums › Cutaneous Melanoma Community › Value of PET for Stage III Cutaneous Melanoma

  • Post
    • February 14, 2014 at 5:47 pm
    BrianP
    Participant
     

    TAKE-HOME MESSAGE

     

    • This meta-analysis incorporated data from 623 patients with stage III (node-positive) melanoma in which FDG-PET was used for staging. Results showed that FDG-PET could impact management (eg, avoidance of radical lymph node dissection) in 20% to 25% of these patients and had a positive predictive value of 75%.
    • These data suggest FDG-PET should be considered as part of preoperative staging for these patients.

    – Richard Bambury, MD

     

    ABSTRACT

     

    Purpose

    The objective of this study was to review the collective experience and utility of FDG-PET scans (FDG-PET) in the detection of systemic metastases in patients with stage III melanoma.

    Methods

    A systematic search for relevant studies published between 1990 and 2012 was performed. We included English language studies that evaluated melanoma patients with stage III disease, with at least 10 patients per study, and collected statistical data to assess FDG-PET utility in the detection of distant metastases. The SIGN tool was used to evaluate methodological quality and a meta-analysis was performed using Stata statistical software to quantify the clinical utility of FDG-PET.

    Results

    The systematic search yielded 9 studies eligible for inclusion in quantitative analyses with a total of 623 patients. The overall sensitivity of FDG-PET in detecting systemic metastases was 89.42% (95% CI: 65.07-97.46), and specificity was 88.78% (95% CI: 77.04-94.91). The pooled positive likelihood ratio was 7.97 (95% CI: 3.58-17.71) and the negative likelihood ratio was 0.12 (95% CI: 0.03-0.47). The area under the summary receiver operating curve (SROC) was 0.94 (95% CI: 0.92-0.96) and the diagnostic odds ratio (DOR) was 66.84 (95% CI: 10.66-418.89). A change in stage and/or management was noted in 22% (126/573) of patients when FDG-PET was utilized.

    Conclusions

    Our findings indicate that FDG-PET may be useful in detecting distant metastases in patients with stage III melanoma. For this highly selected group of patients, FDG-PET has a high sensitivity, specificity and performance, frequently leading to a change in treatment plan.

     

    Surgical Oncology

    Value of Positron Emission Tomography Scan in Stage III Cutaneous Melanoma: A Systematic Review and Meta-Analysis

    Surg Oncol 2014 Jan 26;[EPub Ahead of Print], AM Rodriguez Rivera, H Alabbas, A Ramjaun, A-N Meguerditchian

     

Viewing 2 reply threads
  • Replies
      • February 15, 2014 at 1:25 am
      heiditemple
      Participant

      This is very interesting!  When I had my SNB, 4/8 of the lymph nodes my doctor removed were positive.  Then he did the radical neck dissection, and no further nodes were found.  I wonder if they would have been able to determine no further lymph nodes were positive with an additional PET scan.  

      • February 15, 2014 at 1:25 am
      heiditemple
      Participant

      This is very interesting!  When I had my SNB, 4/8 of the lymph nodes my doctor removed were positive.  Then he did the radical neck dissection, and no further nodes were found.  I wonder if they would have been able to determine no further lymph nodes were positive with an additional PET scan.  

      • February 15, 2014 at 1:25 am
      heiditemple
      Participant

      This is very interesting!  When I had my SNB, 4/8 of the lymph nodes my doctor removed were positive.  Then he did the radical neck dissection, and no further nodes were found.  I wonder if they would have been able to determine no further lymph nodes were positive with an additional PET scan.  

Viewing 2 reply threads

Tagged: 

  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.